Page last updated: 2024-11-05

triallate and Coronary Artery Disease

triallate has been researched along with Coronary Artery Disease in 1 studies

Triallate: A pre-emergence, selective herbicide for the control of wild oats in various crops.

Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Thuesen, AL1
Riber, LP1
Veien, KT1
Christiansen, EH1
Jensen, SE1
Modrau, I1
Andreasen, JJ1
Borregaard, B1
Junker, A1
Mortensen, PE1
Jensen, LO1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Fractional Flow Reserve Versus Angiography Randomization for Graft Optimization Trial[NCT02477371]100 participants (Actual)Interventional2014-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for triallate and Coronary Artery Disease

ArticleYear
Health-Related Quality of Life and Angina in Fractional Flow Reserve- Versus Angiography-Guided Coronary Artery Bypass Grafting: FARGO Trial (Fractional Flow Reserve Versus Angiography Randomization for Graft Optimization).
    Circulation. Cardiovascular quality and outcomes, 2021, Volume: 14, Issue:6

    Topics: Canada; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Stenosis; Fr

2021